Literature DB >> 22486369

Spectroscopic, molecular modeling, and NMR-spectroscopic investigation of the binding mode of the natural alkaloids berberine and sanguinarine to human telomeric G-quadruplex DNA.

Irene Bessi1, Carla Bazzicalupi, Christian Richter, Hendrik R A Jonker, Krishna Saxena, Claudia Sissi, Matteo Chioccioli, Sara Bianco, Anna Rita Bilia, Harald Schwalbe, Paola Gratteri.   

Abstract

G-quadruplex structures can be formed at the single-stranded overhang of telomeric DNA, and ligands able to stabilize this structure have recently been identified as potential anticancer drugs. Among the potential G-quadruplex binders, we have studied the binding ability of berberine and sanguinarine, two members of the alkaloid family, an important class of natural products long known for medicinal purpose. Our spectroscopic (CD, NMR, and fluorescence) studies and molecular modeling approaches revealed binding modes at ligand-complex stoichiometries >1:1 and ligand self-association induced by DNA for the interactions of the natural alkaloids berberine and sanguinarine with the human telomeric G-quadruplex DNA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22486369     DOI: 10.1021/cb300096g

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  23 in total

1.  ESI-MS Investigation of an Equilibrium between a Bimolecular Quadruplex DNA and a Duplex DNA/RNA Hybrid.

Authors:  Monica L Birrento; Tracy M Bryan; Siritron Samosorn; Jennifer L Beck
Journal:  J Am Soc Mass Spectrom       Date:  2015-04-24       Impact factor: 3.109

2.  Human Telomeric G-Quadruplex Structures and G-Quadruplex-Interactive Compounds.

Authors:  Clement Lin; Danzhou Yang
Journal:  Methods Mol Biol       Date:  2017

3.  Pyridine Derivative of the Natural Alkaloid Berberine as Human Telomeric G4-DNA Binder: A Solution and Solid-State Study.

Authors:  Francesco Papi; Carla Bazzicalupi; Marta Ferraroni; Giulia Ciolli; Paolo Lombardi; Asma Yasmeen Khan; Gopinatha Suresh Kumar; Paola Gratteri
Journal:  ACS Med Chem Lett       Date:  2020-02-07       Impact factor: 4.345

Review 4.  Engineering Saccharomyces cerevisiae to produce plant benzylisoquinoline alkaloids.

Authors:  Jianing Han; Yinan Wu; Yilun Zhou; Sijin Li
Journal:  Abiotech       Date:  2021-07-18

5.  Effects of codon optimization, N-terminal truncation and gene dose on the heterologous expression of berberine bridge enzyme.

Authors:  Zixuan Xu; Liqiong Xia; Mengshan Sun; Peng Huang; Jianguo Zeng
Journal:  World J Microbiol Biotechnol       Date:  2022-03-22       Impact factor: 3.312

6.  Berberine Molecular Recognition of the Parallel MYC G-Quadruplex in Solution.

Authors:  Jonathan Dickerhoff; Nicole Brundridge; Scott A McLuckey; Danzhou Yang
Journal:  J Med Chem       Date:  2021-10-22       Impact factor: 7.446

7.  Thermodynamic fingerprints of ligand binding to human telomeric G-quadruplexes.

Authors:  Matjaž Bončina; Črtomir Podlipnik; Ivo Piantanida; Julita Eilmes; Marie-Paule Teulade-Fichou; Gorazd Vesnaver; Jurij Lah
Journal:  Nucleic Acids Res       Date:  2015-11-05       Impact factor: 16.971

8.  Solution Structure of Ternary Complex of Berberine Bound to a dGMP-Fill-In Vacancy G-Quadruplex Formed in the PDGFR-β Promoter.

Authors:  Kai-Bo Wang; Jonathan Dickerhoff; Danzhou Yang
Journal:  J Am Chem Soc       Date:  2021-09-29       Impact factor: 16.383

9.  Selective lighting up of epiberberine alkaloid fluorescence by fluorophore-switching aptamer and stoichiometric targeting of human telomeric DNA G-quadruplex multimer.

Authors:  Lihua Zhang; Hua Liu; Yong Shao; Clement Lin; Huan Jia; Gang Chen; Danzhou Yang; Ying Wang
Journal:  Anal Chem       Date:  2014-12-09       Impact factor: 6.986

10.  The crystal structure of human telomeric DNA complexed with berberine: an interesting case of stacked ligand to G-tetrad ratio higher than 1:1.

Authors:  Carla Bazzicalupi; Marta Ferraroni; Anna Rita Bilia; Francesca Scheggi; Paola Gratteri
Journal:  Nucleic Acids Res       Date:  2012-10-26       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.